Analysis Article • Jul 14
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 20, 2026
DataAggregated Company Financials
Companies7
- 7D-6.1%
- 3M-10.3%
- 1Y-22.3%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 6.3%, driven by Oxford Nanopore Technologies declining 6.7%. Meanwhile, Oxford BioDynamics actually outperformed within the industry, gaining 25% in the last week. The industry has fallen 22% in the last year. Earnings are forecast to grow by 52% annually.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 20 Jul 2026 | UK£1.3b | UK£323.1m | -UK£164,731,254.00 | 1178.4x | -7.9x | 4x |
| Wed, 17 Jun 2026 | UK£1.4b | UK£323.0m | -UK£166,018,254.00 | 1243.9x | -8.3x | 4.3x |
| Fri, 15 May 2026 | UK£1.4b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.6x | 4.5x |
| Sun, 12 Apr 2026 | UK£1.3b | UK£323.0m | -UK£156,192,254.00 | 9.7x | -8.1x | 3.9x |
| Tue, 10 Mar 2026 | UK£1.4b | UK£324.0m | -UK£161,423,254.00 | 10.2x | -8.4x | 4.2x |
| Thu, 05 Feb 2026 | UK£1.7b | UK£304.6m | -UK£159,441,254.00 | 7.7x | -10.7x | 5.6x |
| Sat, 03 Jan 2026 | UK£1.4b | UK£304.6m | -UK£159,441,254.00 | 8.2x | -9x | 4.7x |
| Mon, 01 Dec 2025 | UK£1.6b | UK£303.9m | -UK£162,910,254.00 | 7.3x | -9.7x | 5.2x |
| Wed, 29 Oct 2025 | UK£1.5b | UK£304.3m | -UK£163,156,254.00 | 8.5x | -9.3x | 5x |
| Fri, 26 Sep 2025 | UK£1.7b | UK£304.0m | -UK£163,375,352.00 | 10x | -10.2x | 5.5x |
| Sun, 24 Aug 2025 | UK£2.2b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -13.9x | 7.6x |
| Tue, 22 Jul 2025 | UK£1.6b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -10.1x | 5.6x |
| Thu, 19 Jun 2025 | UK£1.5b | UK£319.7m | -UK£191,105,155.00 | 6.6x | -8x | 4.8x |
| Sat, 17 May 2025 | UK£1.7b | UK£313.2m | -UK£193,016,833.70 | 11.5x | -8.6x | 5.3x |
| Mon, 14 Apr 2025 | UK£1.5b | UK£315.4m | -UK£186,148,089.85 | 6.3x | -8.3x | 4.9x |
| Wed, 12 Mar 2025 | UK£1.5b | UK£320.9m | -UK£182,046,330.80 | 6.4x | -8.1x | 4.6x |
| Fri, 07 Feb 2025 | UK£1.9b | UK£307.0m | -UK£195,589,675.68 | 7.2x | -9.9x | 6.3x |
| Sun, 05 Jan 2025 | UK£1.9b | UK£307.0m | -UK£195,600,753.84 | 7.4x | -9.7x | 6.2x |
| Tue, 03 Dec 2024 | UK£2.1b | UK£306.6m | -UK£194,991,179.76 | 8.3x | -10.6x | 6.7x |
| Thu, 31 Oct 2024 | UK£2.0b | UK£304.7m | -UK£192,548,944.90 | 10.9x | -10.6x | 6.7x |
| Sat, 28 Sep 2024 | UK£2.2b | UK£303.6m | -UK£191,718,111.40 | 11.1x | -11.4x | 7.2x |
| Mon, 26 Aug 2024 | UK£1.8b | UK£295.5m | -UK£188,218,412.70 | 12.4x | -9.8x | 6.3x |
| Wed, 24 Jul 2024 | UK£1.8b | UK£295.3m | -UK£189,738,047.67 | 12.4x | -9.3x | 6x |
| Fri, 21 Jun 2024 | UK£1.5b | UK£295.9m | -UK£190,274,851.23 | 11.4x | -8x | 5.1x |
| Sun, 19 May 2024 | UK£1.6b | UK£294.6m | -UK£187,453,754.66 | 8063.9x | -8.7x | 5.6x |
| Tue, 16 Apr 2024 | UK£1.6b | UK£317.7m | -UK£178,574,182.13 | 11.9x | -9x | 5x |
| Thu, 14 Mar 2024 | UK£1.9b | UK£295.5m | -UK£212,815,702.27 | 7176x | -8.8x | 6.3x |
| Sat, 10 Feb 2024 | UK£2.1b | UK£285.9m | -UK£189,301,187.46 | 7107.4x | -11x | 7.3x |
| Mon, 08 Jan 2024 | UK£3.1b | UK£450.0m | -UK£173,987,191.00 | 62.1x | -17.9x | 6.9x |
| Wed, 06 Dec 2023 | UK£3.0b | UK£454.1m | -UK£169,391,315.00 | 48.6x | -17.9x | 6.7x |
| Fri, 03 Nov 2023 | UK£3.0b | UK£458.6m | -UK£165,536,978.00 | 46.8x | -18.3x | 6.6x |
| Sun, 01 Oct 2023 | UK£3.0b | UK£448.8m | -UK£169,206,255.00 | 66.1x | -17.9x | 6.7x |
| Tue, 29 Aug 2023 | UK£3.1b | UK£476.5m | -UK£126,784,080.00 | 70.6x | -24.2x | 6.4x |
| Thu, 27 Jul 2023 | UK£3.5b | UK£476.0m | -UK£124,358,582.00 | 69.6x | -27.8x | 7.3x |
Price to Earnings Ratio
-27.8x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.0x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 0.97% | |
| Healthcare | -0.29% | |
| Life Sciences | -6.12% | |
| Clinical Research and Equipment | -6.12% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| OBD Oxford BioDynamics | UK£0.0013 | 25.0% +UK£1.1m | -77.9% | PS4.5x | |
| IXI IXICO | UK£0.085 | 3.0% +UK£545.1k | -20.6% | PS2.5x |
